AGGRASTAT Israel - English - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Aggrastat 0.05mg/mL Solution, Solution for Intravenous Infusion Malta - English - Medicines Authority

aggrastat 0.05mg/ml solution, solution for intravenous infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for infusion - tirofiban 50 µg - antithrombotic agents

Fibrostat 281.0 MCG/1 ML Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

fibrostat 281.0 mcg/1 ml

شركة أدوية الحكمة - hikma pharmaceuticals - tirofiban hcl 281.0 mcg/1 ml - 281.0 mcg/1 ml